Special Issue Less than 1 min.Read Fostering Thought leadership in Healthcare By Anup Soans March 27, 2025 FacebookTwitterPinterestWhatsApp … Free Membership Required You must be a Free member to access this content. Join Now Already a member? Log in here Hot this week Digital in Pharma The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient? September 9, 2026 0 How wearables, diagnostics, AI and continuous monitoring are moving... Featured Article RPG-Raghava and Lessons From a Decade of Indian Pharma M&A September 5, 2026 0 RPG Active Pharma’s agreement to acquire the API and... Healthcare Ececutive Pharmacy of the World Pricing Paradox September 1, 2026 0 India occupies an extraordinary position in global pharmaceuticals. It... Featured Article Why The Government Must Stop Playing Market Trader And Start Being The Sheriff August 30, 2026 0 India has two very different pharmaceutical regulators living inside... MedicinMan Pharma Pulse MedicinMan Pharma Pulse: August 2026 August 27, 2026 0 🚀 The Mega-Merger That Wasn't Early August saw the... Topics Digital in Pharma The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient? 0 How wearables, diagnostics, AI and continuous monitoring are moving... Featured Article RPG-Raghava and Lessons From a Decade of Indian Pharma M&A 0 RPG Active Pharma’s agreement to acquire the API and... Healthcare Ececutive Pharmacy of the World Pricing Paradox 0 India occupies an extraordinary position in global pharmaceuticals. It... Featured Article Why The Government Must Stop Playing Market Trader And Start Being The Sheriff 0 India has two very different pharmaceutical regulators living inside... MedicinMan Pharma Pulse MedicinMan Pharma Pulse: August 2026 0 🚀 The Mega-Merger That Wasn't Early August saw the... Featured Article GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat? 0 STOP PRESS August 10, 2026: Regulatory Authorisation — The UK... Exclusive Report How To See Dr Reddy’s Nestle In The Wellness Shift 0 GLP-1 medicines such as semaglutide and tirzepatide are changing... The Pharma Executive How To Power The India Biopharma Regulatory Revolution Now 0 Beyond the Pharmacy of the World: Why India's Biopharma... Related Articles Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel? Special Issue August 20, 2026 Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie Special Issue April 4, 2026 Strategic Communications for Healthcare Brands Exclusive Articles June 25, 2025 Sales View – On-the-Go Information, Insights & Learning for Pharma Professionals Special Issue July 5, 2019 Indian Pharma Market Highlights Special Issue November 12, 2018 Previous articleTop 25 Indian Pharma Companies by Revenues in 2024Next articleIndia’s Medical Devices Market: Strategic Implications and Key Investors
